Inventor · disambiguated record
Mary P. Lambert
Also filed as: LAMBERT MARY P
8 granted patents·16 pending applications·274 citations·filing 1997–2025
88Inventor score
Top patents by PatentIndex Score
24 records- 0193US6218506B1Amyloid β protein (globular assembly and uses thereof)UNIV NORTHWESTERN·Filed 1997·Granted Apr 17, 2001·215 cites·8 claims
- 0292US7780963B2Anti-ADDL antibodies and uses thereofMERCK & CO INC·Filed 2005·Granted Aug 24, 2010·25 cites·14 claims
- 0389US7638283B2Amyloid β protein (globular assembly and uses thereof)UNIV NORTHWESTERN·Filed 2005·Granted Dec 29, 2009·11 cites·2 claims
- 0487US7811563B2Anti-addl antibodies and uses thereofUNIV NORTHWESTERN·Filed 2005·Granted Oct 12, 2010·9 cites·14 claims
- 0581US8383113B2Anti-ADDL antibodies and uses thereofUNIV NORTHWESTERN·Filed 2012·Granted Feb 26, 2013·4 cites·12 claims
- 0676US8889138B2Anti-ADDL antibodies and uses thereofACTON PAUL·Filed 2010·Granted Nov 18, 2014·3 cites·12 claims
- 0776US8128930B2Anti-ADDL antibodies and uses thereofACTON PAUL·Filed 2010·Granted Mar 6, 2012·3 cites·13 claims
- 0869US2021386879A1Method for detecting soluble oligomeric amyloid betaUNIV NORTHWESTERN·Filed 2021·Application pending·0 cites
- 0964US8507206B2Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)LAMBERT MARY P·Filed 2005·Granted Aug 13, 2013·4 cites·1 claims
- 1062US2014322731A1AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-BINDING MOLECULES, AND USES THEREOFUNIV NORTHWESTERN·Filed 2014·Application pending·0 cites
- 1161US2017209604A1Method for detecting soluble oligomeric amyloid betaUNIV NORTHWESTERN·Filed 2017·Application pending·0 cites
- 1258US2009285804A1Anti-ADDLs antibodies and uses thereofKLEIN WILLIAM L·Filed 2009·Application pending·0 cites
- 1357US2007213512A1Amyloid beta peptide analogs and assemblies thereofKRAFFT GRANT A·Filed 2007·Application pending·0 cites
- 1457US2016213794A1Amyloid beta-derived diffusible ligands (addls), addl-surrogates, addl-binding molecules and uses thereofUNIV NORTHWESTERN·Filed 2016·Application pending·0 cites
- 1556US2013150560A1AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-SURROGATES, ADDL-BINDING MOLECULES, AND USES THEREOFUNIV NORTHWESTERN·Filed 2012·Application pending·0 cites
- 1656US2013236466A1AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-SURROGATES, ADDL-BINDING MOLECULES, AND USES THEREOFUNIV NORTHWESTERN·Filed 2012·Application pending·0 cites
- 1756US2013078269A1Amyloid beta peptides, assemblies thereof, and related methodsUNIV NORTHWESTERN·Filed 2012·Application pending·0 cites
- 1855US2003068316A1Anti-ADDL antibodies and uses thereofFiled 2002·Application pending·0 cites
- 1954US2025262337A1Method for detecting soluble oligomeric amyloid betaUNIV NORTHWESTERN·Filed 2025·Application pending·0 cites
- 2054US2007048312A1Anti-ADDL antibodies and uses thereofKLEIN WILLIAM L·Filed 2006·Application pending·0 cites
- 2147US2008176252A1Amyloid beta-derived diffusible ligands (ADDLs), ADDL-surrogates, ADDL-binding molecules, and uses thereofKRAFFT GRANT A·Filed 2005·Application pending·0 cites
- 2246US2013330837A1Monoclonal antibodies that target pathological assemblies of amyloid beta (abeta)ACUMEN PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2337US2006178302A1Amyloid beta protein (globular assembly and uses thereof)NORTHWESTERN UNIVERSITY & THE·Filed 2005·Application pending·0 cites
- 2433US2008306074A1Compositions Comprising Addl Receptors, Related Compositions, and Related MethodsLACOR PASCALE N·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →